Alivus Life Sciences Limited

Alivus Life Sciences Limited is an Indian pharmaceutical company specializing in the development, manufacturing, and marketing of high-value, non-commoditized active pharmaceutical ingredients (APIs) primarily for chronic therapeutic areas. It offers a diverse portfolio of around 151 API molecules used in conditions such as cardiovascular diseases, central nervous system disorders, diabetes, oncology, pain management, and anti-infectives. The company serves a global customer base across India, Europe, North America, Latin America, and Japan, providing contract development and manufacturing services to multinational and specialty pharmaceutical companies. With manufacturing facilities in multiple Indian locations and an extensive R&D presence, Alivus plays a significant role in supplying critical APIs worldwide. It operates as a subsidiary of Nirma Limited and has evolved from Glenmark Life Sciences Limited, emphasizing innovation and quality in pharmaceutical APIs for diverse therapeutic areas.